Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Activated autologous dendritic cells for gastric cancer
NCT03410732Phase 2Unknown
- Sponsor
- Lanzhou University
- Start
- Jul 2017
- Primary completion
- Jul 2020
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in gastric cancer (GC) (2 arms), sponsored by Lanzhou University. Primary endpoint: Progression-Free Survival at 3 years. Status: unknown.
02
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT03410732.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03410732.